Abstract:Aging is the main risk factor for neurodegenerative diseases. In aging, microglia undergoes phenotypic changes compatible with their activation. Glial activation can lead to neuroinflammation, which is increasingly accepted as part of the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD). We hypothesize that in aging, aberrant microglia activation leads to a deleterious environment and neurodegeneration. In aged mice, microglia exhibit an increased expression of cytokines and an exacerbated inflammatory response to pathological changes. Whereas LPS increases nitric oxide (NO) secretion in microglia from young mice, induction of reactive oxygen species (ROS) predominates in older mice. Furthermore, there is accumulation of DNA oxidative damage in mitochondria of microglia during aging, and also an increased intracellular ROS production. Increased ROS activates the redox-sensitive nuclear factor kappa B, which promotes more neuroinflammation, and can be translated in functional deficits, such as cognitive impairment. Mitochondria-derived ROS and cathepsin B, are also necessary for the microglial cell production of interleukin-1β, a key inflammatory cytokine. Interestingly, whereas the regulatory cytokine TGFβ1 is also increased in the aged brain, neuroinflammation persists. Assessing this apparent contradiction, we have reported that TGFβ1 induction and activation of Smad3 signaling after inflammatory stimulation are reduced in adult mice. Other protective functions, such as phagocytosis, although observed in aged animals, become not inducible by inflammatory stimuli and TGFβ1. Here, we discuss data suggesting that mitochondrial and endolysosomal dysfunction could at least partially mediate age-associated microglial cell changes, and, together with the impairment of the TGFβ1-Smad3 pathway, could result in the reduction of protective activation and the facilitation of cytotoxic activation of microglia, resulting in the promotion of neurodegenerative diseases.

Glial aging and its impact on central nervous system myelin regeneration

Microglia Impede Oligodendrocyte Generation in Aged Brain

Microglial Dysfunction in Brain Aging and Neurodegeneration

Replenishing the Aged Brains: Targeting Oligodendrocytes and Myelination?

Microglia regulation of central nervous system myelin health and regeneration

Senescent-like microglia limit remyelination through the senescence associated secretory phenotype

Impact of age-related neuroglial cell responses on hippocampal deterioration

Aging compromises oligodendrocyte precursor cell maturation and efficient remyelination in the monkey brain

Ageing impairs the regenerative capacity of regulatory T cells in mouse central nervous system remyelination

Rejuvenation of Regeneration in the Aging Central Nervous System.

Emerging role of senescent microglia in brain aging-related neurodegenerative diseases

Navigating oligodendrocyte precursor cell aging in brain health

Microglial cell dysregulation in brain aging and neurodegeneration

Old Maids: Aging and Its Impact on Microglia Function

Demyelinating processes in aging and stroke in the central nervous system and the prospect of treatment strategy

Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination

Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation

The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases

[Neuroscience] Remyelination in the Central Nervous System

Oligodendrocytes and myelin: Active players in neurodegenerative brains?

Astrocyte-Oligodendrocyte interaction regulates central nervous system regeneration